Kevin D. Bunker - Chief Scientific Officer at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
ZNTL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin D. Bunker since 11/21/2023

Holdings reported by Kevin D. Bunker for Zentalis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 835K $8.59M $10.29 Dec 20, 2023 Direct
Common Stock 15K $154K $10.29 Dec 20, 2023 Indirect
Common Stock 350 $3.6K $10.29 Dec 20, 2023 As UTMA custodian for sons

Transactions reported by Kevin D. Bunker for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.